Saima Aijaz

1. Aijaz, S. (2020). Tracing the origins of the novel coronavirus SARS-CoV-2. JNU-ENVIS. 25 (1):19-20
2. Singh A.P., Sharma S., Pagarware K., Siraji R. A., Ansari I., Mandal A., Walling P. and  Aijaz S. (2018). Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation. Scientific Reports 8: 3719
3. Singh AP and Aijaz S (2016). Enteropathogenic E. coli:Breaking the intestinal tight junction barrier. F1000Research. 4:231.
4. Singh AP and Aijaz S (2015). Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis. Bioengineered. 6(6): 335-341.
5. Nie M, Aijaz S, Leefa Chong San IV, Balda MS, Matter K. (2009). The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Reports 10:1125-1131.
6. Aijaz S, Sanchez-Heras E, Balda MS, Matter K. (2007). Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2. BMC Cell Biology, 8:49.
7. Aijaz S, Balda MS, Matter K. (2006) Tight junctions: Molecular architecture and function. International Reviews in Cytology; 248: 261-298.
8. Matter K, Aijaz S, Tsapara A, Balda MS. (2005) Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Current Opinion in Cell Biology; 17(5): 453-458.
9. Aijaz S, D'Atri F, Citi S, Balda MS, Matter K. (2005). Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signalling and G1/S phase transition. Developmental Cell; 8(5): 777-786.

Total Published ResearchArticles in National/International Journals: 19

Total Published Abstracts in National/International Journals: 5